| The TB portals: an open-access, web-based platform for global drug-resistant-tuberculosis data sharing and analysis A Rosenthal, A Gabrielian, E Engle, DE Hurt, S Alexandru, V Crudu, ... Journal of clinical microbiology 55 (11), 3267-3282, 2017 | 120 | 2017 |
| Outcomes of bedaquiline treatment in patients with multidrug-resistant tuberculosis L Mbuagbaw, L Guglielmetti, C Hewison, N Bakare, M Bastard, E Caumes, ... Emerging infectious diseases 25 (5), 936, 2019 | 108 | 2019 |
| Lung tissue concentrations of pyrazinamide among patients with drug-resistant pulmonary tuberculosis RR Kempker, MT Heinrichs, K Nikolaishvili, I Sabulua, N Bablishvili, ... Antimicrobial agents and chemotherapy 61 (6), 10.1128/aac. 00226-17, 2017 | 69 | 2017 |
| Prisons as ecological drivers of fitness-compensated multidrug-resistant Mycobacterium tuberculosis SM Gygli, C Loiseau, L Jugheli, N Adamia, A Trauner, M Reinhard, ... Nature medicine 27 (7), 1171-1177, 2021 | 63 | 2021 |
| Clinical outcomes among patients with drug-resistant tuberculosis receiving bedaquiline-or delamanid-containing regimens RR Kempker, L Mikiashvili, Y Zhao, D Benkeser, K Barbakadze, ... Clinical infectious diseases 71 (9), 2336-2344, 2020 | 55 | 2020 |
| Six-month response to delamanid treatment in MDR TB patients C Hewison, G Ferlazzo, Z Avaliani, A Hayrapetyan, S Jonckheere, ... Emerging infectious diseases 23 (10), 1746, 2017 | 54 | 2017 |
| Examples of bedaquiline introduction for the management of multidrug-resistant tuberculosis in five countries L Guglielmetti, C Hewison, Z Avaliani, J Hughes, N Kiria, N Lomtadze, ... The International Journal of Tuberculosis and Lung Disease 21 (2), 167-174, 2017 | 51 | 2017 |
| Is 6 months of bedaquiline enough? Results from the compassionate use of bedaquiline in Armenia and Georgia C Hewison, M Bastard, N Khachatryan, T Kotrikadze, A Hayrapetyan, ... The International Journal of Tuberculosis and Lung Disease 22 (7), 766-772, 2018 | 44 | 2018 |
| Genomic analyses of Mycobacterium tuberculosis from human lung resections reveal a high frequency of polyclonal infections M Moreno-Molina, N Shubladze, I Khurtsilava, Z Avaliani, N Bablishvili, ... Nature communications 12 (1), 2716, 2021 | 34 | 2021 |
| Availability and costs of medicines for the treatment of tuberculosis in Europe G Günther, L Guglielmetti, C Leu, C Lange, F van Leth, H Hafizi, ... Clinical microbiology and infection 29 (1), 77-84, 2023 | 31 | 2023 |
| The relative transmission fitness of multidrug-resistant Mycobacterium tuberculosis in a drug resistance hotspot C Loiseau, EM Windels, SM Gygli, L Jugheli, N Maghradze, D Brites, ... Nature communications 14 (1), 1988, 2023 | 27 | 2023 |
| Cost-effectiveness of bedaquiline, pretomanid and linezolid for treatment of extensively drug-resistant tuberculosis in South Africa, Georgia and the Philippines GB Gomez, M Siapka, F Conradie, N Ndjeka, AMC Garfin, N Lomtadze, ... BMJ open 11 (12), e051521, 2021 | 25 | 2021 |
| Cycloserine and linezolid for tuberculosis meningitis: pharmacokinetic evidence of potential usefulness RR Kempker, AGC Smith, T Avaliani, M Gujabidze, T Bakuradze, ... Clinical Infectious Diseases 75 (4), 682-689, 2022 | 22 | 2022 |
| A Comparison of the Xpert MTB/RIF and MTBDRplus 2 Assays in Georgia N Bablishvili, N Tukvadze, Z Avaliani, HM Blumberg, RR Kempker The international journal of tuberculosis and lung disease: the official …, 2015 | 21 | 2015 |
| Long term outcomes of patients with tuberculous meningitis: the impact of drug resistance EE Evans, T Avaliani, M Gujabidze, T Bakuradze, M Kipiani, S Sabanadze, ... PLoS One 17 (6), e0270201, 2022 | 20 | 2022 |
| What is behind programmatic treatment outcome definitions for tuberculosis? Z Avaliani, O Gozalov, G Kuchukhidze, A Skrahina, V Soltan, ... European Respiratory Journal 56 (1), 2020 | 18 | 2020 |
| Classifying recurrent Mycobacterium tuberculosis cases in Georgia using MIRU-VNTR typing N Maghradze, L Jugheli, S Borrell, N Tukvadze, R Aspindzelashvili, ... PLoS One 14 (10), e0223610, 2019 | 18 | 2019 |
| Long-term follow-up reveals high posttreatment mortality rate among patients with extensively drug-resistant tuberculosis in the country of Georgia M Frank, N Adamashvili, N Lomtadze, E Kokhreidze, Z Avaliani, ... Open Forum Infectious Diseases 6 (4), ofz152, 2019 | 17 | 2019 |
| A comparison of linezolid lung tissue concentrations among patients with drug-resistant tuberculosis RR Kempker, MT Heinrichs, K Nikolaishvili, I Sabulua, N Bablishvili, ... European Respiratory Journal 51 (2), 2018 | 17 | 2018 |
| Mentoring in Global Health: formative evaluation of tuberculosis research training programs in Ethiopia and Georgia DL Comeau, K Mishkin, N Tukvadze, Z Avaliani, RR Kempker, ... The American journal of tropical medicine and hygiene 99 (3), 565, 2018 | 15 | 2018 |
